Pinnacle Financial Partners’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $323K | Buy |
4,394
+472
| +12% | +$34.7K | 0.01% | 374 |
|
|
2024
Q4 | $257K | Buy |
3,922
+14
| +0.4% | +$917 | 0.01% | 398 |
|
|
2024
Q3 | $304K | Buy |
3,908
+953
| +32% | +$74.2K | 0.01% | 375 |
|
|
2024
Q2 | $230K | Sell |
2,955
-48
| -2% | -$3.74K | ﹤0.01% | 405 |
|
|
2024
Q1 | $203K | Sell |
3,003
-442
| -13% | -$29.9K | ﹤0.01% | 430 |
|
|
2023
Q4 | $232K | Buy |
+3,445
| New | +$232K | 0.01% | 392 |
|
|
2017
Q3 | – | Sell |
-9,233
| Closed | -$314K | – | 288 |
|
|
2017
Q2 | $314K | Buy |
9,233
+229
| +3% | +$7.79K | 0.04% | 234 |
|
|
2017
Q1 | $280K | Buy |
+9,004
| New | +$280K | 0.06% | 208 |
|
|
2016
Q4 | – | Sell |
-6,697
| Closed | -$202K | – | 237 |
|
|
2016
Q3 | $202K | Hold |
6,697
| – | – | 0.05% | 263 |
|
|
2016
Q2 | $202K | Sell |
6,697
-18,884
| -74% | -$570K | 0.05% | 254 |
|
|
2016
Q1 | $720K | Sell |
25,581
-9,608
| -27% | -$270K | 0.18% | 136 |
|
|
2015
Q4 | $1.2M | Sell |
35,189
-2,344
| -6% | -$79.6K | 0.37% | 81 |
|
|
2015
Q3 | $1.2M | Buy |
37,533
+273
| +0.7% | +$8.69K | 0.38% | 81 |
|
|
2015
Q2 | $1.19M | Buy |
37,260
+1,336
| +4% | +$42.6K | 0.38% | 81 |
|
|
2015
Q1 | $1.23M | Buy |
35,924
+4,174
| +13% | +$143K | 0.41% | 79 |
|
|
2014
Q4 | $1.12M | Buy |
31,750
+318
| +1% | +$11.2K | 0.39% | 81 |
|
|
2014
Q3 | $1.12M | Buy |
31,432
+1,278
| +4% | +$45.7K | 0.43% | 73 |
|
|
2014
Q2 | $1.12M | Sell |
30,154
-818
| -3% | -$30.4K | 0.45% | 71 |
|
|
2014
Q1 | $1.01M | Buy |
30,972
+2,026
| +7% | +$65.7K | 0.45% | 75 |
|
|
2013
Q4 | $859K | Buy |
28,946
+4,160
| +17% | +$123K | 0.39% | 81 |
|
|
2013
Q3 | $644K | Buy |
+24,786
| New | +$644K | 0.32% | 80 |
|